STING1 and neoplasm: The delivery of a STING agonist through this system significantly inhibited tumor growth and extended the survival time of mice.635 Besides, various other delivery systems, including nanocarriers, microparticles, and hydrogels, are under development and have shown superior anti-tumor activity in preclinical studies compared to traditional methods.636–638